RBC Capital Markets raised its price target on Cameco (CCO.TO, CCJ) to C$175 from C$160 on Monday.
Analyst Andrew D. Wong maintained an Outperform rating on shares of the Saskatchewan-based uranium company.
"We continue to see Cameco as best-positioned to benefit from strong nuclear growth momentum and a constructive uranium price outlook," the analyst said.
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.